Interpreting the MINT randomized clinical trials: let us stick to the facts

In January 2018, a Daring Discourse[1][1] approved by the American Society of Regional Anesthesia and Pain Medicine (ASRA) board of directors was published in Regional Anesthesia and Pain Medicine ( RAPM ). This article represented an educated and analytical commentary on the MINT randomized